跳至主要内容
临床试验/ISRCTN70607306
ISRCTN70607306已完成不适用

In-vivo cross-over study to test impact of a specific strain of Lactobacillus reuteri (DSMZ17648 (Pylopass™ / Lonza) on infection by Helicobacter pylori as determined by 13C urea breath test

onza Ltd (Switzerland)0 个研究点目标入组 20 人开始时间: 2012年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •1. Aged 18 to 75 years
  • •2. Male and female participants
  • •3. Infection by H.pylori with by 13C urea breath test =12

排除标准

  • •1. Intake of any medication interfering with the action of the lactobacilli
  • •2. Previous surgical procedures affecting stomach or small intestine with potential interference with the study, e.g. gastrectomy or gastric bypass, diabetes type 1 or 2
  • •3. Familiar lipid metabolism diseases, liver disease, kidney insufficiency, autoimmune disease, organ transplantation
  • •4. Weight changes >3 kg over the last 3 months
  • •5. Eradication therapy
  • •6. Lactose intolerance
  • •7. Oral intake of antibiotics < 3 months ago
  • •8. Intake of PPIs or H2 antagonists
  • •9. Pregnancy or lactation
  • •10. Alcohol or drug abuse
  • •11. Psychiatric diseases
  • •12. Participation at other clinical trials at the same time

研究者

发起方
onza Ltd (Switzerland)

相似试验